Edgewise Therapeutics EWTX
NASDAQ EWTX
$40.48 -0.12 (-0.30%)
At close: Oct 1, 2026 · 4:00 PM EDT

Edgewise Therapeutics (EWTX) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Edgewise Therapeutics (EWTX) posted Liabilities and Shareholders Equity of $479.69 million for Q2 2026, down 21.8% from $613.33 million a year earlier and down 7.5% from the prior quarter.

Analysis

Edgewise Therapeutics (EWTX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Edgewise Therapeutics' Liabilities and Shareholders Equity came in at $552.6 million, up 13.5% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 33.3% (FY2020 to FY2025).
  • In prior years, Edgewise Therapeutics' Liabilities and Shareholders Equity was $486.82 million in FY2024 (+43.2%), $340.04 million in FY2023 (-7.4%), $367.1 million in FY2022 (+28.7%) and $285.23 million in FY2021 (+117.5%).
  • The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q1 2025.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in six of the last eight quarters, with growth averaging 15.6%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2021, with growth of 117.5%; the weakest was Q2 2026, with a decline of 21.8%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $518.52 million (Q1 2026), $552.6 million (Q4 2025) and $583.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Edgewise Therapeutics 4.38 Bn 4.38 Bn - 479.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 479.69 Mn
Mar 31, 2026 518.52 Mn
Dec 31, 2025 552.60 Mn
Sep 30, 2025 583.47 Mn
Jun 30, 2025 613.33 Mn
Mar 31, 2025 454.39 Mn
Dec 31, 2024 486.82 Mn
Sep 30, 2024 511.28 Mn
Jun 30, 2024 531.65 Mn
Mar 31, 2024 553.81 Mn
Dec 31, 2023 340.04 Mn
Sep 30, 2023 311.36 Mn
Jun 30, 2023 330.63 Mn
Mar 31, 2023 346.40 Mn
Dec 31, 2022 367.10 Mn
Sep 30, 2022 377.15 Mn
Jun 30, 2022 257.40 Mn
Mar 31, 2022 272.75 Mn
Dec 31, 2021 285.23 Mn
Sep 30, 2021 294.45 Mn
API Access

Edgewise Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EWTX&period=max&api_key=YOUR_API_KEY